Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FEHJH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $92,874
Award facts
- Contract value 100% obligated
- $92,874.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This contract, valued at $92,874.34, is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vehicle running through December 2026 that provides comprehensive pharmaceutical support to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. All of AmerisourceBergen's reviewed contract awards with DLA demonstrate open competition and firm fixed pricing structures, showcasing the company's capability to meet diverse federal medical supply requirements. Biktarvy, an antiretroviral medication used in HIV treatment, aligns with the company's demonstrated expertise in delivering specialty pharmaceutical products to support Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FEHJH?
SPE2DB25FEHJH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FEHJH worth?
The government has obligated $92,874 on SPE2DB25FEHJH.
Is contract SPE2DB25FEHJH an order under another contract?
Yes. SPE2DB25FEHJH is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEHJH competed?
The extent of competition for SPE2DB25FEHJH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award